GSK profit hit by pricing pressure, sees lower 2020 profit

(Reuters) - GlaxoSmithKline on Wednesday reported quarterly profit that fell short of analysts' expectations because of pricing pressure, mainly hitting its respiratory drugs, and the drugmaker said adjusted earnings for the year could fall as much as 4 percent. GSK shares were down 2.6% at 1,767.8 pence as of 1226 GMT.The company said it has begun its planned split into two companies following the merger of its over-the-counter products into a venture with Pfizer.Sales rose 11% to 8.90..